Lack of association of fibrinogen, lipoprotein(a), and albumin excretion rate with low birthweight

2000 ◽  
Vol 30 (4) ◽  
pp. 203-205 ◽  
Author(s):  
S. Bo ◽  
P. Cavallo-Perin ◽  
L. Scaglione ◽  
G. Pagano
Keyword(s):  
Low Birthweight ◽  
Excretion Rate ◽  
Albumin Excretion Rate ◽  
Lipoprotein A ◽  
Albumin Excretion

Relationship of Lipoprotein(a) and Its Phenotypes with the Albumin Excretion Rate in Diabetic Patients: A Multivariate Analysis

Nephron ◽  
2000 ◽  
Vol 85 (1) ◽  
pp. 27-33 ◽  
Author(s):  
Cristina Hernández ◽  
Pilar Chacón ◽  
Ramón Martí ◽  
Luis García-Pascual ◽  
Jordi Mesa ◽  
...  
Keyword(s):  
Multivariate Analysis ◽  
Excretion Rate ◽  
Albumin Excretion Rate ◽  
Diabetic Patients ◽  
Lipoprotein A ◽  
Albumin Excretion ◽  
Relationship Of

Effects of Dietary Modification on Albumin Excretion Rate

2009 ◽  
Vol 53 (4) ◽  
pp. 576-578
Author(s):  
Mahboob Rahman ◽  
Michael C. Smith
Keyword(s):  
Excretion Rate ◽  
Albumin Excretion Rate ◽  
Dietary Modification ◽  
Albumin Excretion

scholarly journals The expression of POMC and AgRP in brain and kidney tissues at different stages of diabetic nephropathy rats

2021 ◽  
Vol 1 (1) ◽  
pp. 43-49
Author(s):  
Shasha Liu ◽  
Jingjing Da ◽  
Jiayu Li ◽  
Rong Dong ◽  
Jing Yuan ◽  
...  
Keyword(s):  
Body Weight ◽  
Diabetic Nephropathy ◽  
Blood Glucose ◽  
Urinary Albumin Excretion ◽  
Excretion Rate ◽  
Kidney Tissue ◽  
Albumin Excretion Rate ◽  
Urinary Albumin ◽  
Urinary Albumin Excretion Rate ◽  
Albumin Excretion

Abstract Objective To explore the changes of proopiomelanocortin (POMC) and Agouti-Related Peptide (AgRP) expression in brain and kidney tissues under insulin intervention at different stages of diabetic nephropathy (DN) rats. Methods The male Sprague-Dawley (SD) rats of DN were treated with high-fat diet for 8 weeks and induced by intraperitoneally injection of streptozotocin (30 mg/kg) for one time. Then DN rats were also injected insulin subcutaneously at 2–5 U/(kg·24 h) from initiation of the streptozotocin. Kidney tissue, blood sample, and 24 h-urine were collected to detect the ratio of kidney/body weight, blood glucose and 24-h urinary albumin excretion rate at different stages (4, 8, 12, and 16 weeks). Immunohistochemistry assay was used to measure the expression of POMC and AgRP at different stages of DN rats. Results The DN rats were established successfully. With the progression of DN, blood glucose, 24-h urinary albumin excretion rate and kidney body weight ratio increased significantly, while decreased when insulin was injected. Immunohistochemistry showed that the expression levels of POMC were decreased gradually in brain and kidney tissues. Conversely, the expression of AgRP in kidney was highest at week 8 and then decreased gradually. The effect of insulin on normalizing POMC and AgRP expression in brain and renal tissues was also observed in DKD rats. Conclusion With the progression of DN, the expression of POMC and AgRP in kidney tissues was observed at different stages of disease, and their expressions were significantly normalized by insulin. The mechanism of in situ expression of POMC and AGRP in kidney to the progression of DN needs further investigations.

Glycosaminoglycans as a Possible Tool for Micro- and Macroalbuminuria in Diabetic Patients. A Pilot Study

1997 ◽  
Vol 25 (2) ◽  
pp. 81-86 ◽  
Author(s):  
G Sorrenti ◽  
M Grimaldi ◽  
N Canova ◽  
E Palazzini ◽  
N melchionda
Keyword(s):  
Type Ii Diabetes ◽  
Excretion Rate ◽  
Albumin Excretion Rate ◽  
Favourable Effect ◽  
Diabetic Patients ◽  
Type Ii ◽  
Therapeutic Tool ◽  
Albumin Excretion ◽  
End Of Treatment

The aim was to investigate sulodexide as a possible therapeutic tool for treating micro- and macroalbuminuria in diabetic patients. Fifteen patients (13 micro- and 2 macroalbuminuric) with Type II diabetes, were treated with 600 lipoprotein-lipase releasing units of sulodexide by the intramuscular route, daily for 28 days, and followed up for 2 months. The main evaluation parameter was the albumin excretion rate. At the end of treatment, six of the 13 microalbuminuric patients showed a decrease in the albumin excretion rate, which increased again in three of the six during follow-up. In the two macroalbuminuric patients the albumin excretion rate decreased at the end of treatment and remained unchanged after a further 2 months. Overall analysis (15 patients) showed a significant decrease ( P < 0.05) in the albumin excretion rate compared with baseline. Metabolic control and blood pressure remained unchanged during the entire period of study. No adverse events were registered. It is concluded that sulodexide administration has a favourable effect in reducing the albumin excretion rate in Type II diabetic patients with micro- and macroalbuminuria.

scholarly journals SP140KDIGO 2012 CLASSIFICATION AND URINARY ALBUMIN EXCRETION RATE (%UAE) AS PREDICTIVE FACTORS OF RENAL BIOPSY LESIONS IN PARAPROTEIN ASSOCIATED DISEASE

2016 ◽  
Vol 31 (suppl_1) ◽  
pp. i132-i132
Author(s):  
Marisa Santostefano ◽  
Elena Zamagni ◽  
Valentina Demelas ◽  
Giulia Schiavone ◽  
Katia Mancuso ◽  
...  
Keyword(s):  
Renal Biopsy ◽  
Predictive Factors ◽  
Urinary Albumin Excretion ◽  
Excretion Rate ◽  
Albumin Excretion Rate ◽  
Urinary Albumin ◽  
Urinary Albumin Excretion Rate ◽  
Albumin Excretion

Iloprost decreases urinary albumin excretion rate in patients with diabetic nephropathy

1993 ◽  
Vol 21 (2-3) ◽  
pp. 115-122 ◽  
Author(s):  
Hideo Shindo ◽  
Masato Tawata ◽  
Norihiko Yokomori ◽  
Yoshiyuki Hosaka ◽  
Masayuki Ohtaka ◽  
...  
Keyword(s):  
Diabetic Nephropathy ◽  
Urinary Albumin Excretion ◽  
Excretion Rate ◽  
Albumin Excretion Rate ◽  
Urinary Albumin ◽  
Urinary Albumin Excretion Rate ◽  
Albumin Excretion
Sign in / Sign up

Export Citation Format

Share Document